Structure assignment, conformational properties and discovery of potential targets of the Ugi cinnamic adduct NGI25. Issue 4 (4th March 2023)

• Record Type: Journal Article
• Authors: Georgiou, Nikitas; Gouleni, Niki; Chontzopoulou, Eleni; Skoufas, George S.; Gkionis, Anastasios; Tzeli, Demeter; Vassiliou, Stamatia; Mavromoustakos, Thomas
• Is Part Of: Journal of biomolecular structure & dynamics. Volume 41:Issue 4(2023)
• Page Start: 1253
• Page End: 1266
• Publication Date: 2023-03-04
• Subjects: Cinnamic analog -- synthesis -- spectroscopy -- molecular dynamics -- molecular docking; Biomolecules -- Periodicals; Molecular structure -- Periodicals; Molecular Biology -- Periodicals; Biomechanics -- Periodicals; 572
• DOI: 10.1080/07391102.2021.2017356
• Languages: English
• ISSNs: 0739-1102

Abstract

Abstract: The structure assignment and conformational analysis of cinnamic derivative N-benzyl-N-(2-(cyclohexylamino)-2-oxoethyl) cinnamamide (NGI25) was carried out through Nuclear Magnetic Resonance (NMR) spectroscopy, Molecular Dynamics (MD) and Quantum Mechanics (QM), i.e. semiempirical and Density Functional Theory (DFT) calculations. Moreover, Homonuclear (COSY, NOESY) and heteronuclear (HSQC, HMBC) experiments were applied to assign its protons and carbons. After structure identification, NGI25 was subjected to computational calculations to reveal its most favorable conformations. In particular, MD studies were performed in two different solvents, DMSO of intermediate polarity and hydrophobic CHCl3 . The obtained results suggest that NGI25 adopts similar conformations in both environments. In particular, the two aromatic rings of the molecule reside in spatial vicinity, while they remain quite distant from the cyclohexane. 2D NOESY experiments confirmed the in silico MD and QM calculations. Finally, molecular docking calculations were performed in order to reveal possible enzyme-targets for NGI25. Swiss target module was used to guide the discovery of new targets based on the structure of NGI. Indeed, it was predicted that NGI25 inhibited butyrylcholinesterase (BCHE) and lipoxygenase (LOX). Molecular docking experiments, followed by Molecular Dynamics studies, confirmed the favorable binding of NGI25 to both enzymes. Communicated by Ramaswamy H. Sarma